Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of Evercode™ Whole Blood Fixation, a new kit that enables immediate ...
A team from the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) has developed an innovative ...
The full abstracts will be available on the Caris website following the presentations. The Caris Precision Oncology Alliance consists of 98 cancer centers, academic institutions, research consortia ...
ABILENE, Texas, Dec. 3, 2025 /PRNewswire/ -- Officials from Abilene Christian University (ACU) Athletics, Golf Channel and HNS Sports Group announced on Wednesday a multi-year partnership to host a ...
Twenty-five years ago, the release of the first complete Arabidopsis thaliana genome marked a pivotal turning point in plant ...
Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced today that it has welcomed Dr. Josh ...
It is great to welcome UAMS to the Caris POA. Their unwavering commitment to excellence perfectly aligns with our commitment to advance biomarker-driven precision oncology,” said James Hamrick, MD, ...
Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...
Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion ...
TEL AVIV, Israel & LEHI, Utah & HOUSTON & FREMONT, Calif.--(BUSINESS WIRE)--MyHeritage, the leading global platform for family history and DNA testing, announced today a landmark move to Whole Genome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results